Stockreport

Recursion Pharmaceuticals to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF first-quarter 2025 results soon. (Find the latest earnings estimates and surprises on Zacks Earnings Calendar.) The Zacks Consensus Estimate is pegged at a loss of 44 [Read more]